| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1037391460 |
| P356 | DOI | 10.1007/S00406-008-0831-X |
| P932 | PMC publication ID | 3085762 |
| P698 | PubMed publication ID | 19194646 |
| P5875 | ResearchGate publication ID | 23981047 |
| P50 | author | Peter Falkai | Q58295323 |
| P2093 | author name string | Roberto D'Amelio | |
| Thomas Wobrock | |||
| Helmut Sittinger | |||
| Bernd Behrendt | |||
| P2860 | cites work | A review of MRI findings in schizophrenia | Q24657354 |
| Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study | Q28259349 | ||
| Dual diagnosis: a review of etiological theories | Q28287738 | ||
| A New Depression Scale Designed to be Sensitive to Change | Q29614720 | ||
| Brain neuroimaging in cannabis use: a review | Q31060237 | ||
| Compounded brain volume deficits in schizophrenia-alcoholism comorbidity | Q33186290 | ||
| Meta-analysis of regional brain volumes in schizophrenia | Q33885349 | ||
| Psychosocial approaches to dual diagnosis | Q33886044 | ||
| Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients. | Q51988878 | ||
| Correlates of patterns of substance abuse among patients with schizophrenia. | Q52037728 | ||
| Tardive dyskinesia in psychiatric patients with substance use disorders. | Q52061337 | ||
| Effect of substance misuse in early psychosis. | Q53568076 | ||
| Volume of the cingulate and outcome in schizophrenia. | Q53879058 | ||
| Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. | Q55056971 | ||
| Schizophrenia: the fundamental questions | Q57382396 | ||
| Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes | Q60445926 | ||
| Substance use: a powerful predictor of relapse in schizophrenia | Q71505986 | ||
| Cannabis abuse and the course of recent-onset schizophrenic disorders | Q72371028 | ||
| Temporolimbic volume reductions in schizophrenia | Q74091279 | ||
| Substance misuse, psychiatric disorder and violent and disturbed behaviour | Q33927523 | ||
| Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study | Q33962711 | ||
| Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden | Q34201663 | ||
| Effects of frequent marijuana use on brain tissue volume and composition | Q34507628 | ||
| Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study | Q34508346 | ||
| Precipitation and determination of the onset and course of schizophrenia by substance abuse--a retrospective and prospective study of 232 population-based first illness episodes | Q34522385 | ||
| Lack of hippocampal volume change in long-term heavy cannabis users | Q34556425 | ||
| Studies of individuals with schizophrenia never treated with antipsychotic medications: a review | Q34985042 | ||
| Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature | Q34989186 | ||
| Revising axis V for DSM-IV: a review of measures of social functioning | Q35348329 | ||
| Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia | Q38401669 | ||
| Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London | Q39587016 | ||
| Drug and alcohol problems amongst individuals with severe mental health problems in an inner city area of the UK. | Q39589192 | ||
| Psychopathology in dual diagnosis and non-addicted schizophrenics--are there differences? | Q40662165 | ||
| Thalamic volumes in patients with first-episode schizophrenia | Q40715821 | ||
| Prevalence of alcohol and drug abuse in schizophrenic inpatients | Q40821996 | ||
| Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study | Q40858744 | ||
| Influence of cannabis abuse on schizophrenic psychopathology | Q41113315 | ||
| Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients | Q43723165 | ||
| Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients | Q43873742 | ||
| Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study | Q44252090 | ||
| Prevalence of substance misuse in first-episode psychosis | Q44262046 | ||
| Cannabis and brain morphology in recent-onset schizophrenia | Q44461653 | ||
| Post-mortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics. Initial results from a new brain collection | Q44514127 | ||
| Significance of cocaine history in schizophrenia | Q45179111 | ||
| Altered brain tissue composition in heavy marijuana users | Q45193430 | ||
| Reduced cerebral grey matter observed in alcoholics using magnetic resonance imaging | Q46302591 | ||
| Decreased frontal white-matter volume in chronic substance abuse | Q46590337 | ||
| Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging | Q46759026 | ||
| Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function | Q47574608 | ||
| Reliability and validity of the German version of the European Addiction Severity Index (EuropASI). | Q47641029 | ||
| Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia | Q48135249 | ||
| Brain morphological abnormality in schizophrenia is independent of country of origin | Q48207515 | ||
| Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia | Q48257411 | ||
| Brain volume changes in first-episode schizophrenia: a 1-year follow-up study | Q48452819 | ||
| Decreased caudate volume in neuroleptic-naive psychotic patients | Q48454154 | ||
| A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures | Q48519543 | ||
| A volumetric MRI study of the entorhinal cortex in first episode neuroleptic-naive schizophrenia | Q48581063 | ||
| Dorsolateral prefrontal and superior temporal volume deficits in first-episode psychoses that evolve into schizophrenia | Q48771978 | ||
| Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia | Q48868128 | ||
| Drug abuse in schizophrenic patients: clinical correlates and reasons for use. | Q48876065 | ||
| Magnetic resonance imaging of the thalamus in first-episode psychosis | Q49120340 | ||
| Schizophrenia, alcohol abuse, and violent behavior: a 26-year followup study of an unselected birth cohort. | Q50868857 | ||
| Cannabis and schizophrenia: results of a follow-up study. | Q51090957 | ||
| Clinical effects of recent cocaine use on patients with acute schizophrenia. | Q51121373 | ||
| Substance use disorder and the early course of illness in schizophrenia and affective psychosis. | Q51552241 | ||
| P433 | issue | 1 | |
| P921 | main subject | psychosis | Q170082 |
| substance abuse | Q3184856 | ||
| P304 | page(s) | 28-36 | |
| P577 | publication date | 2009-02-04 | |
| P1433 | published in | European Archives of Psychiatry and Clinical Neuroscience | Q661388 |
| P1476 | title | Comorbid substance abuse and brain morphology in recent-onset psychosis | |
| P478 | volume | 259 |
| Q36354947 | An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use. |
| Q52625218 | Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders. |
| Q43176482 | Auditory mismatch negativity deficits in long-term heavy cannabis users. |
| Q35536880 | Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders. |
| Q30558464 | Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence |
| Q37643444 | Cannabis use and cognition in schizophrenia |
| Q45171625 | Combined grey matter VBM and white matter TBSS analysis in young first episode psychosis patients with and without cannabis consumption |
| Q39340879 | Effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia |
| Q34282907 | Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studies |
| Q48118197 | Impulsivity-related brain volume deficits in schizophrenia-addiction comorbidity |
| Q37358080 | MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse |
| Q34130565 | Reduced prefrontal gyrification in obsessive-compulsive disorder |
| Q34028727 | Striatal dopamine release in schizophrenia comorbid with substance dependence |
| Q21559698 | Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings |
| Q34531537 | The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability |
Search more.